Summary
aTyr Pharma
Founded in 2005
Description
aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based therapeutics for the treatment of rare diseases, including facioscapulohumeral muscular dystrophy (FSHD) and limb-girdle muscular dystrophy (LGMD) 2B. The Company is developing Resolaris, an intravenous protein therapeutic for the treatment of rare myopathies with an immune component (RMICs). The Company is investigating Resolaris in patients with LGMD2B. The Company is conducting approximately three open label trials in patients with early onset FSHD, in adult patients with FSHD or LGMD2B and a long-term extension study in adult patients with FSHD. The Company has not generated any revenues.
Strengths
- aTyr Pharma has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Since aTyr Pharma was founded, the company has grown faster than the industry average
Weaknesses
- The number of employees is not growing as fast as the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
aTyr Pharma's annual revenue
$2053000
Based on Kona Equity data
-
Revenue per employee
$41898
-
Annual revenue growth since founding
$108052
Employee Count
49 employees
-
Employee growth rate from first known quarter to current
-32.3%
Executives
G Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Web Analysis
-
Rank
3.66 M
-
Page views per visitor
2.0
-
Daily time
-
Location
Unlock unlimited leads
Similar Companies
Bellerophon Therapeutics, Inc.
bellerophon.com- Founded in 2014
- Location: Warren, NJ
- Annual Revenue: $6.8M
- Employees: 20
- Bellerophon Therapeutics is a clinical stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well studied molecules ...
Lumos Pharma
lumos-pharma.com- Founded in 1999
- Location: Austin, TX
- Annual Revenue: $341.0K
- Employees: 32
- Lumos Pharma is a clinical stage biopharmaceutical company based in Austin, Texas. Their mission is to develop new therapies for people with rare diseases. They prioritize their focus on areas where the medical need is high and the pathophysiology is c...
Viking Therapeutics
vikingtherapeutics.com- Founded in 2012
- Location: San Diego, CA
- Annual Revenue: $4.4M
- Employees: 21
- Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Company's clinical program, VK5211, is an orally available drug candidate, which is in Phase II clinical trial for acute rehabilitation following non-e…
ContraFect
contrafect.com- Founded in 2008
- Location: Yonkers, NY
- Annual Revenue: $4.9M
- Employees: 23
- ContraFect Corporation is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug resistant pathogens, particularly those treated i...
Inozyme Pharma Inc
inozyme.com- Founded in 2017
- Location: Boston, MA
- Annual Revenue: $14.7M
- Employees: 50
- Breakthrough Solutions at the Speed of Science.
PhaseBio Pharmaceuticals
phasebio.com- Founded in 2002
- Location: Malvern, PA
- Annual Revenue: $10.9M
- Employees: 60
- PhaseBio is focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications.
Key Information
- Name: aTyr Pharma
- Category: Pharmaceuticals
- Industry: Biotechnology company
- SIC: 87; 873
- NAICS: 54; 541
See similar companies
-
By City San Diego Small Biotechnology company in San Diego Mid-size Biotechnology company in San Diego Pharmaceuticals in San Diego Small Pharmaceuticals in San Diego Mid-size Pharmaceuticals in San Diego
-
By State CA Small companies in CA Pharmaceuticals in CA Small Pharmaceuticals in CA Mid-size Pharmaceuticals in CA Small Biotechnology company in CA Mid-size Biotechnology company in CA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology company Small Biotechnology company Mid-size Biotechnology company Pharmaceuticals and Biotechnology company
-
Firmographic data G Score of 3 Founded in 2005 SIC: 87 SIC: 873 NAICS: 54 NAICS: 541 #Manufacturing #Pharmaceuticals #Business Services #Chemicals & Related Products #Research & Development
Frequently Asked Questions
aTyr Pharma's headquarters are located at 3545 John Hopkins Ct Ste 250 San Diego, CA 92121.
aTyr Pharma's official website is atyrpharma.com
aTyr Pharma's annual revenue is $2.1 M.
aTyr Pharma's SIC: 87; 873
aTyr Pharma's NAICS: 54; 541.
aTyr Pharma has 49 employees
aTyr Pharma is in the industry of Pharmaceuticals.
